About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN
My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Journal of Ocular Pharmacology and Therapeutics

Editor: W. Daniel Stamer, PhD

ISSN: 1080-7683 • 10 Issues Annually • Online ISSN: 1557-7732

Current Volume: 30

Latest Impact Factor* is 1.420

*2013 Journal Citation Reports® published by Thomson Reuters, 2014

Editorial Board

Editor-in-Chief

W. Daniel Stamer, PhD
Duke University
Durham, NC  
 

Associate Editors

Drug Delivery
Uday B. Kompella, PhD
University of Colorado Denver
Denver, CO

 
Retinal Pharmacology
Michael R. Niesman, PhD
MingSight Pharmaceuticals
San Diego, CA
 

Ocular Surface Pharmacology
Michael E. Stern, PhD
Allergan, Inc.
Irvine, CA


Aqueous Humor Dynamics
Carol B. Toris, PhD
University of Nebraska Medical Center
Omaha, NE

Editorial Board

Makoto Aihara MD, PhD
Shirato Eye Clinic
Tokyo, Japan

Esen K. Akpek, MD
Johns Hopkins University
Baltimore, MD

Francine Behar-Cohen, MD, PhD
Institut des Cordeliers
Paris, France

Curtis R. Brandt, PhD
University of Wisconsin-Madison
Madison, WI

Alain M. Bron, MD 
University Hospital
Dijon, France

  
Abbot Clark, PhD
The University of North Texas Health Science Center 
Fort Worth, TX
 

Craig E. Crosson, PhD
Medical University of South Carolina
Charleston, SC

Nicholas A. Delamere, PhD
University of Louisville
Louisville, KY

Filippo Drago, MD, PhD
University of Catania Medical School
Catania, Italy

Juana Gallar, MD, PhD
Instituto de Neurociencias UMH-CSIC
San Juan de Alicante, Spain

Linda D. Hazlett, PhD
Wayne State University
Detroit, MI

Jost B. Jonas, MD
Mannheim of the Ruprecht-Karls-University Heidelberg
Mannheim, Germany

Peter F. Kador, PhD
University of Nebraska Medical Center
Omaha, NE 

Jeffrey W. Kiel, PhD
University of Texas Health Science Center at San Antonio
San Antonio, TX      

Achim H. Krauss, PhD
GlaxoSmithKline
King of Prussia, PA

Alan D. Marmorstein, PhD
Mayo Clinic
Rochester, MN 
 

M. Christine McGahan, PhD
North Carolina State University
Raleigh, NC

Claire H. Mitchell, PhD
University of Pennsylvania
Philadelphia, PA

Ashim K. Mitra, PhD
University of Missouri
Kansas City, MO

Gary D. Novack, PhD
Pharma-Logic Development, Inc.
San Rafael, CA

David E. Potter, PhD
Medical University of South Carolina
Charleston, SC

Ganesh Prasanna, PhD
Novartis Institutes for Biomedical Research (NIBR)
Cambridge, MA

Daniel Saban, PhD
Duke University
Durham, NC 

Leopold Schmetterer, PhD
Medical University of Vienna
Vienna, Austria

Naj A. Sharif, PhD
Alcon Research Ltd
Fort Worth, TX

Robert W. Snyder, MD, PhD, PC
University of Arizona
Tucson, AZ

Angela M. Suburo, MD, PhD
Universidad Austral, Pilar
Buenos Aires, Argentina

Khalid F. Tabbara, MD
The Eye Center and The Eye Foundation
   for Research in Ophthalmology
Riyadh, Saudi Arabia

Chi-Ho To, PhD
The Hong Kong Polytechnic University
Kowloon, Hong Kong

Thomas Yorio, PhD
The University of North Texas Health Science Center 
Fort  Worth, TX

Husam S. Younis, PharmD, PhD
Isis Pharmaceuticals, Inc.
Carlsbad, CA

Oliver Zeitz, MD
Bayer Schering Pharma AG
Berlin, Germany

Founding Editor
George C.Y. Chiou, PhD


Editorial Coordinator

Sheryl Nale
OPTjournal@gmail.com

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.